POINTS OF VIEW

At Ankhero, we foster dialogue across the pharma and supply chain ecosystem. This section offers expert insights, diverse views, and commentary on key topics—regulations, tech, and operations—to support informed industry decisions.

Saying the Quiet Things Out Loud

On Oct 9, 2024 the FDA announced further delays to the milestone of the DSCSA regulation. The new dates give manufacturers 6 additional months, wholesalers 9 additional months and non

We discuss the signifcance (or insignificance) that was Nov 27, 2023. What do companies need to know going forward as well as a look back on the last 10 years

This week we talk about a service offering from Jennason called doss digital which helps companies leverage no code/low code technology to build business applications that solve business challenges quickly

We are back with episode 5 of the Saying the Quiet Things Out Loud Podcast. Today we discuss how one single email can provide significant insight into your serialization vendor’s

2 quick takes and the announcement of the Jennason DSCSA Trading Partner Directory Introduction Quick Take #1- DSCSA ‘stabilization’: Don’t let vendors fool you into rushing Quick Take #2: NABP

The FDA has announced a 1 Year enforcement description to the upcoming November DSCSA deadline. In today’s episode we discuss: A summary of the enforcement discretion What additional details companies

Episode 2 of the Saying The Quiet Things Out Loud podcast. Part 1 The next 30 days. What pharma entities need to watch for related to DSCSA Why companies should

The first installment of the Saying The Quiet Things Out Loud Podcast where we will focus on current topics and trends in the pharmaceutical serialization space. In today’s episode we

Points of View - Blog

For companies working in regulated environments, validation is non-negotiable. What happens when the tool you’re relying on starts becoming part of the problem. Delivering meaningful value, or simply the illusion

Are Pfizer leaving them? Seems likely from the attached job posting. A bold move, for sure, but one can only assume there is confidence that change is necessary to leave